Dr. Andrea B. Apolo
Claim this profileNCI - Center for Cancer Research
Studies Bladder Cancer
Studies Genitourinary Cancers
2 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Andrea B. Apolo is currently running
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting1 award Phase 221 criteria
Olaparib
for Bladder Cancer
This trial studies how well olaparib works in patients with advanced bladder and other genitourinary cancers that have DNA-repair defects. Olaparib is a drug that stops cancer cells from fixing their damaged DNA, which can help to stop the cancer from growing. The trial targets patients whose cancers have spread and are not responsive to standard treatments.
Recruiting1 award Phase 220 criteria
More about Andrea B. Apolo
Clinical Trial Related5 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Andrea B. Apolo has experience with
- Olaparib
- Cabozantinib S-malate
- Ipilimumab
- Nivolumab
Breakdown of trials Andrea B. Apolo has run
Genitourinary Cancers
Bladder Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrea B. Apolo specialize in?
Andrea B. Apolo focuses on Bladder Cancer and Genitourinary Cancers. In particular, much of their work with Bladder Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Andrea B. Apolo currently recruiting for clinical trials?
Yes, Andrea B. Apolo is currently recruiting for 2 clinical trials in Bethesda Maryland. If you're interested in participating, you should apply.
Are there any treatments that Andrea B. Apolo has studied deeply?
Yes, Andrea B. Apolo has studied treatments such as Olaparib, Cabozantinib S-malate, Ipilimumab.
What is the best way to schedule an appointment with Andrea B. Apolo?
Apply for one of the trials that Andrea B. Apolo is conducting.
What is the office address of Andrea B. Apolo?
The office of Andrea B. Apolo is located at: NCI - Center for Cancer Research, Bethesda, Maryland 20892 United States. This is the address for their practice at the NCI - Center for Cancer Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.